MX9306031A - Inhibidores sensibilizantes de hiv-1'' sensibilizana individuos infectados con hiv a 'farmacos no nucleosidos para tratar hiv'. - Google Patents

Inhibidores sensibilizantes de hiv-1'' sensibilizana individuos infectados con hiv a 'farmacos no nucleosidos para tratar hiv'.

Info

Publication number
MX9306031A
MX9306031A MX9306031A MX9306031A MX9306031A MX 9306031 A MX9306031 A MX 9306031A MX 9306031 A MX9306031 A MX 9306031A MX 9306031 A MX9306031 A MX 9306031A MX 9306031 A MX9306031 A MX 9306031A
Authority
MX
Mexico
Prior art keywords
hiv
sensitizing
nucleosid
sensitizes
inhibitors
Prior art date
Application number
MX9306031A
Other languages
English (en)
Spanish (es)
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MX9306031A publication Critical patent/MX9306031A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX9306031A 1992-10-28 1993-09-29 Inhibidores sensibilizantes de hiv-1'' sensibilizana individuos infectados con hiv a 'farmacos no nucleosidos para tratar hiv'. MX9306031A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12

Publications (1)

Publication Number Publication Date
MX9306031A true MX9306031A (es) 1994-04-29

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9306031A MX9306031A (es) 1992-10-28 1993-09-29 Inhibidores sensibilizantes de hiv-1'' sensibilizana individuos infectados con hiv a 'farmacos no nucleosidos para tratar hiv'.

Country Status (12)

Country Link
EP (1) EP0666744A1 (no)
JP (1) JPH08502745A (no)
KR (1) KR950703958A (no)
AU (1) AU4848293A (no)
CA (1) CA2145545A1 (no)
CZ (1) CZ69695A3 (no)
FI (1) FI952018A (no)
HU (1) HUT72050A (no)
MX (1) MX9306031A (no)
NO (1) NO951608L (no)
PL (1) PL308551A1 (no)
WO (1) WO1994009781A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
WO2004022060A2 (en) 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. (1h-benzoimidazol-2-yl)-(piperazinyl)-methanone derivatives and related compounds as histamine h4-receptor antagonists for the treatment of inflammatory and allergic disorders
TW201201813A (en) 2010-03-31 2012-01-16 Arqule Inc Substituted benzo-pyrido-triazolo-diazepine compounds
US8569331B2 (en) 2010-11-01 2013-10-29 Arqule, Inc. Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds

Also Published As

Publication number Publication date
EP0666744A1 (en) 1995-08-16
CZ69695A3 (en) 1995-12-13
WO1994009781A1 (en) 1994-05-11
PL308551A1 (en) 1995-08-21
FI952018A0 (fi) 1995-04-27
FI952018A (fi) 1995-04-27
CA2145545A1 (en) 1994-05-11
KR950703958A (ko) 1995-11-17
AU4848293A (en) 1994-05-24
JPH08502745A (ja) 1996-03-26
NO951608D0 (no) 1995-04-27
HUT72050A (en) 1996-03-28
HU9501218D0 (en) 1995-06-28
NO951608L (no) 1995-06-28

Similar Documents

Publication Publication Date Title
MX9204454A (es) Derivados de tiourea para inhibir la replicacion del virus de inmunodeficiencia humana y formulado farmaceutico que los contiene.
AR004700A1 (es) 1alfa, 26 dihidroxi-d-homo-vitamina d3, una composicion farmaceutica que la comprende, un procedimiento para su preparacion y el uso de los mismos en laelaboracion de un medicamento
MX9301929A (es) Derivados de pirimidina y procedimientos para su preparacion.
ES2188782T3 (es) Formulaciones farmaceuticas que contienen darifenacina.
FI940787A0 (fi) Annostusmuoto lääkkeen annostelemiseksi lyhyessä ajanjaksossa
ES2083668T5 (es) Combinaciones antiviricas que contienen analogos de nucleosido.
ES2054860T5 (es) Derivados de 9-halogeno-(z)-prostaglandinas, procedimiento para su preparacion y su utilizacion como medicamentos.
ES2081397T3 (es) O-metil derivados de azitromicina a, procedimiento y productos intermedios para su preparacion, y uso de los mismos en la preparacion de productos farmaceuticos.
AR012294A1 (es) Derivados de sulfonamida, un procedimiento para su preparacion, composiciones farmaceuticas que los contienen, uso de dichos derivados para lapreparacion de un medicamento.
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
KR960700721A (ko) Aids-관련 신경 장애를 치료하기 위한 라모트리진의 사용(use of lamotrigine for treating aids-related neural disorders)
ATE213633T1 (de) Lamotrigin haltiges arzneimittel
MX9306031A (es) Inhibidores sensibilizantes de hiv-1'' sensibilizana individuos infectados con hiv a 'farmacos no nucleosidos para tratar hiv'.
MX9303572A (es) Inhibidores de proteasa del sindrome de inmunodeficiencia humana, procedimiento para su preparacion y formualcion farmaceutica que los contiene.
MX9308025A (es) Compuestos inhibidores de la proteasa del virus dela inmunodeficiencia humana, procedimiento para supreparacion y formulacion farmaceutica que los contiene.
ES2094834T3 (es) Dispositivo para el lavado, para finalidades terapeuticas o de higiene, de conductos internos humanos o animales.
ES2171459T3 (es) Polvo para administracion nasal de farmaco peptidico o proteinaceo.
ES2098792T3 (es) Dihidrogeno-ortofosfato de tilidina, procedimiento para su obtencion y preparaciones farmaceuticas que lo contienen.
KR890009401A (ko) 바이러스를 억제시키는 방법
ES2151922T3 (es) Uso de aspirina para la fabricacion de un medicamento para mejorar la perfusion sanguinea en el utero.
BR0107881A (pt) Uso de fsh tratamento de infertilidade
NO981898D0 (no) Anvendelse av flupirtin for forhindring og behandling av sykdommer som er forbundet med skade pÕ det hematopotiske cellesystem
BR9910201A (pt) Sistema terapêutico transdérmico para emprego de candesartan
ES2065855B1 (es) Procedimiento para la preparacion de nuevos derivados desoxiazafosfolipidicos con accion inhibidora de la fosfolipasa a2, nuevos derivados desoxiazafosfolipidicos obtenidos y utilizacion de los mismos.
HUP0100365A2 (hu) Kombinációs terápia AIDS kezelésére